http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632286-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ef778284e70c25d57bce3b1f357c561 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 |
| filingDate | 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106632286-A |
| titleOfInvention | Pharmaceutical composition as well as preparation method and application thereof |
| abstract | The invention discloses a pharmaceutical composition and application thereof. The pharmaceutical composition is a compound containing a chemical formula (I) or pharmaceutically acceptable salts and pharmaceutically acceptable carriers thereof (the formula is shown in the description). The pharmaceutical composition provided by the invention can be used for preparing an antibacterial drug, in particular preparing a medicine for pretreating or treating vancomycin-resistant bacteria infectious diseases. Experimental data show that the compound is combined with glycopeptide antibacterial drugs, so that the growth of vancomycin-resistant enterococci can be effectively inhibited. |
| priorityDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.